Darren Head joined Great Point Partners’ CEO Advisory Board in 2016 and is currently on the Board of Clinical Supplies Management, a GPP II portfolio company.
Mr. Head is the former President and Chief Executive Officer of Cytovance Biologics, a former GPP I portfolio company. Under his leadership, Cytovance grew revenues over 40% per year during GPP’s investment period and was sold in 2015 for 7.4x invested capital and a 57% IRR. Mr. Head has over 26 years of biological, device and drug manufacturing experience. Prior to joining Cytovance, he served with Immucor as Senior Vice President of Worldwide Operations. Prior to Immucor, Mr. Head led Aronex Pharmaceuticals manufacturing and clinical supply operations in late Phase 3 programs. Additionally, he served in the United States Air Force during Operation Desert Storm.
Mr. Head holds a B.S. in Biology and attended the executive M.B.A. program at Texas A&M.
- Cytovance Biologics – biologic pharmaceuticals